Glenmark Pharma Gets BSE Nod to Merge Subsidiaries With Itself

BSE has approved the merger of Glenmark Pharmaceuticals' two subsidiaries with the pharma company as the amalgamation does not violate securities law. The pharma giant received nod for the merger of Glenmark Generics Ltd and Glenmark Access Ltd with itself, which the Glenmark Pharmaceuticals board had approved in January this year.       'No-objection approval' has been granted to the proposal, the BSE said a letter to Glenmar...